Trials / Recruiting
RecruitingNCT03418350
The Role of Laryngopharyngeal Reflux in IPF
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- National Jewish Health · Academic / Other
- Sex
- All
- Age
- 40 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).
Detailed description
The study team hypothesizes the SGI will correlate more strongly with measures of IPF severity (at baseline and over time) than gastroesophageal reflux (GER) data derived from the esophageal detector channels of a pH/impedance probe.
Conditions
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2025-12-01
- Completion
- 2026-12-01
- First posted
- 2018-02-01
- Last updated
- 2024-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03418350. Inclusion in this directory is not an endorsement.